✦ LIBER ✦
Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis
✍ Scribed by Anthony Russell; Ariel Beresniak; Louis Bessette; Boulos Haraoui; Proton Rahman; Carter Thorne; Ross Maclean; Danielle Dupont
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 183 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.